Home > Compound List > Product Information
Vandetanib-d4_Molecular_structure_CAS_)
Click picture or here to close

Vandetanib-d4

Catalog No. V097102 Name Toronto Research Chemicals
CAS Number Website http://www.trc-canada.com
M. F. C22H24BrFN4O2 Telephone +1 (416) 665-9696
M. W. 475.3539632 Fax +1 (416) 665-4439
Purity Email info@trc-canada.com
Storage Chembase ID: 179440

SYNONYMS

IUPAC name
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-{[1-methyl(2,2,6,6-2H4)piperidin-4-yl]methoxy}quinazolin-4-amine
IUPAC Traditional name
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-{[1-methyl(2,2,6,6-2H4)piperidin-4-yl]methoxy}quinazolin-4-amine
Synonyms
4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-[[1-methyl(piperidin-4-yl)-d4]methoxy]quinazoline
Zactima-d4
N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[[1-methyl-4-(piperidinyl-d4)]methoxy]-4-quinazolinamine
ZD 6474-d4

DATABASE IDS

PROPERTIES

MSDS Link Download
Certificate of Analysis Download

DETAILS

Description (English)
A labelled Vandetanib; a once-daily oral inhibitor of vascular endothelial growth factor receptor-2 and epidermal growth factor receptor kinase activity. The activity of vandetanib plus docetaxel was assessed in patients with previously treated non-small-

REFERENCES

  • Bruns, C., et al.: Clin. Cancer Res., 6, 1936 (2000)
  • Hennequin, L., et al.: J. Med. Chem., 45, 1300 (2000)
  • Park, M., et al.: J. Biol. Chem., 278, 50624 (2000)
  • Arao, T., et al.: Cancer Res., 64, 9101 (2000)
  • Prueitt, R., et al.: Int. J. Cancer, 120, 796